In COVID-19, escalated- vs. prophylactic-dose...

In COVID-19, escalated- vs. prophylactic-dose anticoagulation does not reduce mortality and increases major bleeding.

Abstract

SOURCE CITATION: Ortega-Paz L, Galli M, Capodanno D, et al. Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials. Eur Heart J Cardiovasc Pharmacother. 2021. [Epub ahead of print.] 34519777.

Authors

Chaudhuri D; Rochwerg B

Journal

Annals of Internal Medicine, Vol. 175, No. 2,

Publisher

American College of Physicians

Publication Date

February 1, 2022

DOI

10.7326/j21-0021

ISSN

1056-8751

Associated Experts

Bram Rochwerg

Associate Professor, Faculty of Health Sciences

Visit profile

Labels

In COVID-19, escalated- vs. prophylactic-dose anticoagulation does not reduce mortality and increases major bleeding.

Abstract

Authors

Journal

Publisher

Publication Date

DOI

ISSN

Associated Experts

Labels

Fields of Research (FoR)

Sustainable Development Goals (SDG)

Medical Subject Headings (MeSH)

Contact the Experts team